Literature DB >> 16151289

Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.

Ersin Ulkür1, Oral Oncül, Hüseyin Karagöz, Bahattin Celiköz, Saban Cavuşlu.   

Abstract

Acticoat (Smith and Nephew, Istanbul, Turkey), chlorhexidine acetate 0.5%, and silver sulfadiazine 1% were compared to assess the antibacterial effect of their application on experimental burn wounds in contaminated with Pseudomonas aeruginosa in rats. All treatment modalities were effective against P. aeruginosa because there were significant differences between treatment groups and control groups. The mean eschar concentrations did not differ significantly between Acticoat and chlorhexidine acetate groups, but there were significant differences between the silver sulfadiazine group and the other treatment groups, indicating that silver sulfadiazine significantly eliminated P. aeruginosa more effectively in the tissues than did the other two agents. All treatment modalities were sufficient to prevent the P. aeruginosa from invading to the muscle and from causing systemic infection. In conclusion, silver sulfadiazine is the most effective agent in the treatment of the P. aeruginosa-contaminated burn wounds; Acticoat can be considered as a treatment choice because of its peculiar ability of limiting the frequency of replacing wound dressings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151289     DOI: 10.1097/01.bcr.0000176879.27535.09

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  12 in total

1.  Honey compared with silver sulphadiazine in the treatment of superficial partial-thickness burns.

Authors:  Kamran Ishaque Malik; M A Nasir Malik; Azhar Aslam
Journal:  Int Wound J       Date:  2010-10       Impact factor: 3.315

2.  Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer.

Authors:  Simin Hemati; Omid Asnaashari; Mostafa Sarvizadeh; Behnam Nasiri Motlagh; Mojtaba Akbari; Mina Tajvidi; Abbas Gookizadeh
Journal:  Support Care Cancer       Date:  2011-10-19       Impact factor: 3.603

Review 3.  Silver dressings: their role in wound management.

Authors:  David J Leaper
Journal:  Int Wound J       Date:  2006-12       Impact factor: 3.315

4.  Aloe versus silver sulfadiazine creams for second-degree burns: a randomized controlled study.

Authors:  Ghasemali Khorasani; Seyed Jalal Hosseinimehr; Mohammad Azadbakht; Arman Zamani; Mohammad Reza Mahdavi
Journal:  Surg Today       Date:  2009-06-28       Impact factor: 2.549

Review 5.  Animal models of external traumatic wound infections.

Authors:  Tianhong Dai; Gitika B Kharkwal; Masamitsu Tanaka; Ying-Ying Huang; Vida J Bil de Arce; Michael R Hamblin
Journal:  Virulence       Date:  2011-07-01       Impact factor: 5.882

Review 6.  Topical antimicrobials for burn wound infections.

Authors:  T Dai; Y Y Huang; S K Sharma; J T Hashmi; D B Kurup; M R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2010-06

7.  A geriatric patient with major burns:case report.

Authors:  F Uygur; N Noyan; E Ulkür; B Celiköz
Journal:  Ann Burns Fire Disasters       Date:  2008-03-31

8.  Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats.

Authors:  Hakan Yabanoglu; Ozgur Basaran; Cem Aydogan; Ozlem Kurt Azap; Feza Karakayali; Gokhan Moray
Journal:  Int Surg       Date:  2013 Oct-Dec

9.  Use of a new silver barrier dressing, ALLEVYN Ag in exuding chronic wounds.

Authors:  Paula Kotz; Jane Fisher; Pat McCluskey; Samantha D Hartwell; Hussein Dharma
Journal:  Int Wound J       Date:  2009-06       Impact factor: 3.315

Review 10.  Nanocrystalline silver dressings in wound management: a review.

Authors:  Joy Fong; Fiona Wood
Journal:  Int J Nanomedicine       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.